Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Fubotv Inc (FUBO) Price & Performance

Edgewise Therapeutics Inc. Common StockTrade
Fubotv IncTrade

Price performance (Past 24H)

Key statistics

Edgewise Therapeutics Inc. Common Stock vs Fubotv Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Fubotv Inc trades at $8.22 (market cap $901.97M). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 4.5× Fubotv Inc's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Fubotv Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Fubotv Inc for 35 Days on average.

EWTXFUBO
Market Cap
$4.02B$901.97M
Volume
1,446,1281,439,905
Sector
HealthMedia
52-Week High
$48.35$48.96
52-Week Low
$14.89$8.09
Typical Hold Time
0 Days35 Days
Enterprise Value
$3.56B$1.07B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Fubotv Inc

FUBO stock trades at $8.19, down 6.29% today, reflecting a bearish technical signal. Revenue grew to $1.62 billion in 2024, with net losses narrowing to -$172.25 million, indicating improving profitability trends. The company recently expanded sports streaming partnerships, including a multi-year NHL deal announced September 28, 2026, to enhance content offerings.

The outlook is mixed; deep undervaluation metrics like P/S of 0.16 and analyst consensus price target of $63.38 suggest significant upside, but persistent cash burn and competitive pressures in streaming pose risks. Investor sentiment hinges on execution of Disney-backed turnaround plans targeting $300 million EBITDA by FY28.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWTX
100% Buy0% Sell
Avg holding period · 0 Days
FUBO
60% Buy40% Sell
Avg holding period · 35 Days

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →

About Fubotv Inc

FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.

Read more on FUBO →